266 filings
Page 5 of 14
6-K
6aqm2c rv
21 Sep 20
ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit
9:40am
6-K
om1bx0n32k zlakvf
17 Sep 20
ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020
5:22pm
6-K
6lj2roq8rg xndpf
14 Sep 20
ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
9:10am
6-K
n5gnrr40pclahuzwgw
10 Sep 20
ESSA Pharma to Participate in Multiple Upcoming Investor Conferences
9:10am
S-8
hp0vn7y 0f5hbf790u
13 Aug 20
Registration of securities for employees
12:00am
6-K
6ig164vyvj7l lp
7 Aug 20
Current report (foreign)
12:00am
6-K
bhaxg5u
6 Aug 20
Current report (foreign)
12:19pm
6-K
yhsfhicmsm
31 Jul 20
Current report (foreign)
10:35am
424B5
y6ixtvxrk frjij53a
29 Jul 20
Prospectus supplement for primary offering
9:55pm
6-K
n3r50lyn ri0xe
28 Jul 20
ESSA Pharma Announces Pricing of Public Offering of Common Shares
9:48pm
6-K
62uir 6hu0grkmv5
28 Jul 20
ESSA Pharma Announces Proposed Public Offering of Common Shares
4:24pm
424B5
6vmeg8h
28 Jul 20
Prospectus supplement for primary offering
4:11pm
6-K
w9k6a6ir61bjj36iq
15 Jul 20
ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer
8:33am
S-8
st8tg kege7
29 Jun 20
Registration of securities for employees
12:00am
6-K
wr6qfx hhr
22 Jun 20
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
9:17am
6-K
uezt 1p9nup3
27 May 20
ESSA Pharma to Present at Jefferies Virtual Healthcare Conference
8:37am
6-K
y8kuvoi7
15 May 20
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
8:34am
6-K
51bhu38 65
7 May 20
Current report (foreign)
5:31pm
6-K
p35xs
1 May 20
ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer
12:00am
6-K
sl9yke
15 Apr 20
Current report (foreign)
5:04pm